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Abstract
Target herbal ingredient (THI) is an extract made from two herbs, Scutellariae Radix and Platycodi Radix. It has been developed as a treatment 
for metabolic diseases such as hyperlipidemia, atherosclerosis, and hypertension. One component of these two herbs has been reported to have 
anti-inflammatory, anti-hyperlipidemic, and anti-obesity activities. However, there have been no reports about the effects of the mixed extract of 
these two herbs on metabolic diseases. In this study, we investigated the metabolic effects of THI using a diet-induced obesity (DIO) mouse model.
High-fat diet (HFD) mice were orally administered daily with 250 mg/kg of THI. After 10 weeks of treatment, the THI-administered HFD mice
showed reduction of body weights and epididymal white adipose tissue weights as well as improved glucose tolerance. In addition, the level of
total cholesterol in the serum was markedly reduced. To elucidate the molecular mechanism of the metabolic effects of THI in vitro, 3T3-L1 cells
were treated with THI, after which the mRNA levels of adipogenic transcription factors, including C/EBPα and PPARγ, were measured. The results
show that the expression of these two transcription factors was down regulated by THI in a dose-dependent manner. We also examined the combinatorial
effects of THI and swimming exercise on metabolic status. THI administration simultaneously accompanied by swimming exercise had a synergistic
effect on serum cholesterol levels. These findings suggest that THI could be developed as a supplement for improving metabolic status.
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Introduction3)
Platycodi Radix has long been used as an expectorant in 
traditional Oriental medicine. Recently, it was reported that 
Platycodi Radix has anti-inflammatory, anti-allergy, anti-tumor, 
apoptosis-inducing, and immune-stimulating activities [1-4]. Several 
reports have also shown that platycodin saponins, a major 
component of Platycodi Radix, have beneficial effects on the 
treatment of metabolic disorders, including obesity and hyperli-
pidemia [5]. Platycodi Radix has been found to reduce hepatic 
and serum triglyceride levels in Sprague-Dawley rats fed a 
high-fat diet (HFD) [6] as well as inhibit adipogenesis by modulating 
kruppel-like factor 2 (KLF2) and peroxisome proliferator-activated 
receptor  γ (PPAR-gamma) [7].
Scutellariae Radix has also been widely used for the clinical 
treatment of hyperlipidemia, atherosclerosis, and hypertension in 
East Asian countries, including China, Korea, and Japan. The 
active component of Scutellariae Radix is baicalin, which is well 
known as an anti-inflammatory and antioxidant agent [8-10]. 
Baicalin inhibits adipogenesis through the downregulation of 
pro-adipogenic genes, including PPARγ, C/EBPα, and KLF15, 
as well as the upregulation of anti-adipogenic regulators, 
including C/EBPγ  and KLF2 [11]. It was also reported that 
baicalin exerts an anti-adipogenic effect through the maintenance 
of  β-catenin expression, which is reduced during normal 
adipogenesis [12].
Although Platycodi Radix and Scutellariae Radix show 
anti-adipogenic effects, studies have not been performed on the 
combinatorial effects of Platycodi Radix and Scutellariae Radix 
on metabolic disease. Thus, we examined the metabolic effects 
of a mixture of Platycodi Radix and Scutellariae Radix using 
a diet-induced obesity model. 
Materials and Methods
Chemicals and reagents
Cell culture reagents were obtained from Life Technologies 
(Grand Island, NY, USA). Anti-C/EBPα and anti-C/EBPβ antibodies 
were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, 
USA). Anti-PPARγ antibody and secondary antibody were purchased 
from Cell Signaling (Beverly, MA, USA). Other chemicals were 
purchased from Sigma-Aldrich (St. Louis, MO, USA).
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Animals and experimental groups
All animals were obtained from the Korea Research Institute 
of Bioscience and Biotechnology, Daejoen, Korea. Seven-week- 
old C57BL/6 male mice were subdivided, acclimatized for 1 
week, and divided randomly into five groups: (1) sedentary, 
normal diet, and vehicle treatment (ND-Veh), (2) sedentary, 
high-fat diet, and vehicle treatment (HFD-Veh), (3) sedentary, 
high-fat diet, and THI treatment (HFD-THI), (4) exercise, 
high-fat diet, and vehicle treatment (E/HFD-Veh), and (5) 
exercise, high-fat diet, and THI treatment (E/HFD-THI). Bedding 
was changed once a week, and the temperature and humidity 
were controlled. Mice were housed under 12 hr light/12 hr dark 
conditions. The plans and protocols for animal experiments were 
approved by the Institutional Animal Care and Use Committee 
of Sookmyung Women’s University, Seoul, Korea.
Preparation of herbal mixture
The roots of Platycodon grandiflorum and  Scutellariae 
baicalensis were obtained from Namil Farm & Ginseng Co. 
(Geumsam, Korea); voucher specimens were preserved at 
Chug-Ang University College of Medicine, Seoul, Korea (No. 
2009.11-12). The two herbs were mixed in a 1:1 ratio and 
extracted with 70% ethanol. The extract was concentrated by 
evaporating solvent under low pressure conditions. The final 
yield of extract compared with raw herbal material was 25% 
(w/w).
Diet and THI treatment
Purina Diet (Koatech, Seoul, Korea) was provided to mice in 
the normal diet group, whereas a pellet rodent diet with 60% 
K cal fat (Central Lab. Animal Inc., Seoul, Korea) was provided 
for 10 weeks to the HFD group. Each mouse was administered 
25 mg of THI orally, as determined in previous studies. For the 
vehicle treatment group, the same volume of distilled water was 
administered orally every day for 10 weeks by the same method 
used for THI treatment. Each group comprised six mice, and 
all mice were allowed free access to the described diet and water 
during experimental periods. Body weights and food intake were 
measured weekly at regular times. 
Tissue preparation and blood chemistry
Mice were dissected to collect tissues for analysis. Blood was 
collected from the retro-orbital sinus by using sodium-heparinized 
microhaematocrit capillary tubes (Marienfeld-superior, Lauda- 
Königshofen, Germany) and then transferred to Eppendorf tubes 
and incubated at room temperature. After 3 hr, all samples were 
centrifuged at 13,500 rpm for 5 min, after which serum was taken 
to measure triglyceride, glucose, and total cholesterol levels using 
an automatic blood chemistry analyzer Dry-Chem 4000i (Fujifilm, 
Saitama, Japan) at the Yonsei Laboratory Animal Research 
Center. 
Swimming exercise
For exercise experiments, exercise groups of HFD mice were 
divided into two groups. One group was subjected to exercise 
without administration of THI while the other group was 
subjected to swimming exercise with oral administration of 25 
mg of THI to each mouse. Mice underwent compulsory 
swimming exercise at 9:00 am and 5:00 pm twice a day, 5 days 
per week for 10 weeks. In the first week, mice swam voluntarily 
for 40 min, and this time was increased gradually up to 60 min 
for intensification of exercise. Mice swam at 31℃  in a 
temperature-controlled water bath, and the water bath was 
cleaned once a week. 
RT-PCR analysis
Total RNA samples were prepared by homogenizing epididymal 
tissues and liver tissues with 500 μL of RNA iso-plus (Takara, 
Shiga, Japan). Prepared total RNAs were reverse-transcribed 
using M-MuLV reverse transcriptase (Promega, Madison, WI, 
USA) at 37℃  for 1 hr. PCR for amplification of mRNAs 
encoding hormone-sensitive lipase (HSL), adipose triglyceride 
lipase (ATGL), mitochondrial uncoupling protein 2 (UCP2), and 
carnitine palmitoyltransferase 1a (CPT1a) was performed using 
appropriate primer pairs: ATGL forward, 5’-CTCCGAGAGATG 
TGCAAACA-3’, reverse, 5’-CAGTTCCACCTGCTCAGACA-3’; 
HSL forward, 5’-CTTCCTGCAAGAGTATGTCACG-3’, reverse, 
5’-TGGAGGTGAGATGGTGACTG-3; UCP2 forward, 5’-CTG 
GCAGGTAGCACCACAGGTG-3’, reverse, 5’-GCATGGTAAG 
GGCACAGTGAC-3’; CPT1a forward, 5’-GTCTGGAATCAAC 
TCCTGGAAG-3’, reverse, 5’-CAGTGACGTTGGAAGCTGTA 
G-3’. RT-PCR products were visualized by 1% agarose gel 
electrophoresis, and the intensity of the bands was measured 
using a DNR Bio-Imaging system (Kiryat Anavim, Jerusalem, 
Israel). 
Oral glucose tolerance test (OGTT)
Mice were fasted for 14 hr before experiments, and D-glucose 
(Duchefa Biochemie, Haarlem, Netherlands) was administered to 
mice at a dose of 1 g per kg of body weight. Glucose level 
of the blood taken from the tail vein was measured using 
Accu-Chek (Roche Diagnostics, Basel, Switzerland) at 30 min 
intervals for 120 min. 
Cell culture
The 3T3-L1 cells were purchased from the American Type 
Culture Collection (Manassas, VA, USA). Two days after reaching 
confluence (day 0), 3T3-L1 cells were cultured in Dulbecco’s 200 THI improves metabolic abnormality
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Fig. 1. THI administration reduces body weight in the diet-induced obesity (DIO) 
model.  (A)  Body  weight  changes  were  measured  once  a  week,  and  mice  were 
photographed  after  10  weeks.  HFD-Veh,  high-fat  diet  with  water  administration; 
ND-Veh,  normal  diet  with  water  administration;  HFD-THI,  high-fat  diet  with  THI 
administration. *P < 0.05 and **P < 0.01 indicate statistical significance between the 
HFD-Veh and HFD-THI groups. (B) Food intake per mouse per day was measured. 
Data  show  average  food  intake  over  10  weeks.  All  values  are  given  as  mean ±
SEM  (n = 7)  for  all  groups.
Modified Eagle’s Medium (DMEM) containing 1 μg/mL of 
insulin, 0.25 μM dexamethasone, 0.5 mM 3-isobutyl-1-methyl-
xanthine, and 10% fetal bovine serum (differentiation induction 
medium) for 2 days. Cells were then maintained in DMEM 
containing 1 μg/mL of insulin and 10% fetal bovine serum 
(differentiation maintenance medium). The differentiation 
maintenance medium was changed every 2 days until the cells 
were harvested on day 7. To test the effects of THI on 
adipogenesis, various concentrations of THI were added to the 
differentiation induction and maintenance media until cells were 
harvested. Differentiated cells in each well of 6-well plates were 
harvested in 500 μL of phosphate-buffered saline (PBS), frozen, 
and then sonicated. The triglyceride contents of the cell lysates 
were measured using a TG-S reaction kit (Asan Pharm., Seoul, 
Korea). Lipid droplets in cells were stained with Oil Red O, 
as previously described [13].
Protein extraction and Western blotting
Cultured and differentiated cells were harvested using a cell 
scraper and lysed with ice-cold RIPA buffer containing 25 mM 
Tris-HCl, pH 7.6, 150 mM NaCl, 1% Nonidet P-40, 1% sodium 
deoxycholate, 0.1% SDS, and a protease inhibitor cocktail 
(Sigma-Aldrich). The total cell lysates were centrifuged at 14,000 
rpm for 20 min at 4℃ to remove insoluble materials. The protein 
concentrations were determined using a BCA protein assay kit 
(Pierce, Rockford, IL, USA). Fifty micrograms of protein extract 
was resolved by 10% SDS-polyacrylamide gel electrophoresis 
at 150 mA for 1 hr and then transferred to nitrocellulose 
membranes. The membranes were next blocked for 2 hr at room 
temperature with PBS containing 5% skim milk and 0.1% Tween 
20, incubated with 1:1,000-dilutions of primary antibodies 
overnight at 4℃, and then with horseradish peroxidase-conjugated 
anti-rabbit secondary antibody for 1 hr at room temperature. 
Peroxidase activity was visualized using an ECL kit (Pierce, 
Rockford, IL, USA). 
Statistical analysis
Statistical analysis was performed using SPSS statistical 
software. When differences among the groups were detected by 
one-way factorial ANOVA, Turkey’s test was used. A level of 
significance of P< 0.05 was chosen for all statistical comparisons. 
Data are presented as means ± SEM.
Results
Effects of THI on body weight and food intake
Many herbal extracts were screened for the inhibition of fat 
accumulation in 3T3-L1 cells (data not shown). Two herbs, 
Scutellariae Radix and Platycodi Radix, were finally selected due 
to their strong activities. In this study, we examined the effects 
of the mixed extract of these two herbs, named THI, on metabolic 
abnormality in mice fed a high-fat diet. There are two types of 
obesity animal models available. One includes genetic models 
such as the leptin-deficient ob/ob mouse model and the leptin 
receptor deficient db/db mouse model. The other type includes 
the DIO model. In this study, we used the DIO model to 
determine the effects of THI on obesity since DIO is an 
experimental model with much higher applicability to human 
obesity. Mice were subdivided into three groups: the normal diet 
group with vehicle treatment, the 60% HFD group with vehicle 
treatment, and the 60% HFD group with THI treatment. There 
were significant differences in body weight between the HFD 
and normal diet groups from the first week of the experiment. 
The THI-administered mice showed a more modest increase in 
size and body weight than did the HFD group, although food 
intake was the same for both groups (Fig. 1A and 1B). 
Weight of epididymal white adipose tissue was highly 
increased in the HFD group compared with the normal diet group, Sora Han et al. 201
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Fig. 2. THI administration decreases weights of epididymal adipose tissues. (A) 
Weights of two epididymal adipose tissues were measured after 10 weeks of high-fat 
d i e t  a n d  e x p r e s s e d  a s  g / 1 0 0  g  o f  b o d y  w e i g h t .  ( B )  W h o l e  l i v e r  w eights  were 
measured and expressed as g/100 g of body weight. **P< 0.01 indicates statistical 
significance between HFD-Veh, high-fat diet with water administration and HFD-THI, 
high-fat diet  with THI administration. All  values are  given as  mean ± SEM  (n = 7) 
for  all  groups.
(A) (B) (C) (D)
(E) (F)
Fig. 3. THI reduces total cholesterol levels. (A)  Serum  triglyceride  levels  were  measured (n = 7).  (B)  Serum total cholesterol  levels were  measured  (n = 7). (C-F) Relative 
expression levels of hormone-sensitive lipase (HSL), adipose triglyceride lipase (ATGL), mitochondrial uncoupling protein 2 (UCP2), and carnitine palmitoyltransferase 1a (CPT1a)
mRNA  in  epididymal  white  adipose  tissues  and  skeletal  muscle  tissues  were  determined  using  RT-PCR  (n = 3).  Values  are  given  as  mean ± SEM  **P < 0.01.
(A)
(B) (C)
 
Fig. 4. THI reduces adipogenic differentiation of 3T3-L1 cells in vitro.  (A) 
Intracellular  fat  droplets  in  3T3-L1  cells  were  stained  with  Oil  red  O  dye  after 
adipogenic differentiation for 7 days. (B) Intracellular fat content was compared in 
3T3-L1  cells  after  treatment  with  various  concentrations  of  THI.  (C)  Protein 
expression levels of adipogenic transcription factors, C/EBPα, C/EBPβ, and PPAR
γ, were measured in 3T3-L1 cells. β-actin was used as a loading control. *P <
0.05,  **P < 0.01,  ***P < 0.001  compared  with  untreated  sample.
and the THI-administered HFD group showed a significant 
decrease in adipose tissue weight by as much as 40% compared 
with the HFD group (Fig. 2A). However, liver tissue weights 
were not significantly different among the three groups (Fig. 2B).
Effects of THI on serum levels of triglycerides, total cholesterol, 
and glucose
Since THI administration reduced adipose tissue weight, we 
wondered whether or not THI could induce changes in the serum 
levels of triglycerides and total cholesterol. The level of total 
cholesterol was lower compared with the HFD group (Fig. 3A 
and 3B), whereas the triglyceride level was not reduced to a 
statistically significant level. Next, to determine whether or not 
administration of THI enhances energy expenditure, total RNA 
was isolated from epididymal white adipose tissues. The mRNA 202 THI improves metabolic abnormality
Fig. 5. THI administration improves glucose tolerance. Mice were fasted for 14 
hr before OGTT. Blood glucose levels were measured every 30 min for 120 m in, 
and relative areas under curves (AUC) were calculated. Data are expressed as mean
±S E M  (n=7 ). *P < 0.05,  **P < 0.01,  ***P < 0.001  indicate  statistical  significance 
between HFD-Veh, high-fat diet with water administration and HFD-THI, high-fat diet 
with  THI  administration  groups.
(A) (B) (C)
(D) (E) (F)
Fig. 6. THI administration with swimming exercise synergistically decreases total serum cholesterol levels. (A) Body weight changes were measured 10 weeks after 
high-fat diet (S/HFD-Veh, sedentary high-fat diet with water administration), swimming exercise (E/HFD-Veh, exercising high-fat diet with water administration), and combination
of THI administration and swimming exercise (E/HFD-Veh, exercising high-fat diet with THI administration) (n = 7 for each group).  (B)  Food  intake per mouse  per  day  was 
measured. (C) Epididymal white adipose tissue weight was measured and expressed as g/100 g of body weight. ***P < 0.001 indicates statistical significance of each group 
versus the S/HFD-Veh group. (D) Serum triglycerides levels were measured (n = 5). (E) Total serum cholesterol levels were measured (n = 5). ***P < 0.001 indicates statistical 
significance between indicated groups. (F) Oral glucose tolerance test was performed (n = 7, left), and relative areas under curves (AUC) were calculated. All values are given 
as  mean ± SEM.
levels of hormone-sensitive lipase (HSL) and adipose triglyceride 
lipase (ATGL), which are involved in the mobilization of free 
fatty acids from adipose triacylglycerol stores, were analyzed by 
RT-PCR. There was no significant increase in HSL and ATGL 
mRNA expression (Fig. 3C). The mRNA levels of mitochondrial 
uncoupling protein 2 (UCP2) and carnitine palmitoyltransferase 
1a (CPT1a), which are responsible for energy expenditure, were 
also analyzed by RT-PCR. The levels of UCP2 and CPT1a 
mRNA in adipose and muscle tissues were not changed 
statistically (Fig. 3E and 3F).
THI was also found to inhibit Oil red O-stained fat droplet 
formation, which is a marker of adipogenesis, during adipogenic 
differentiation of 3T3-L1 cells in vitro (Fig. 4A). THI also 
significantly reduced the intracellular fat content in a dose- 
dependent manner (Fig. 4B). To elucidate the molecular mechanism 
of THI action in vitro, the expression levels of major transcription 
factors of adipogenesis were analyzed. It was found that THI 
downregulated the expression of C/EBPα and PPARγ, whereas 
C/EBPβ levels were not changed (Fig. 4C). 
Next, we performed an oral glucose tolerance test. All groups 
of mice were fasted during the night cycle, and glucose was orally 
injected 14 hr after starvation. Blood glucose levels were 
measured at the indicated time points. The THI-administered 
group showed improved oral glucose tolerance compared with 
the HFD group, although the glucose tolerance of the 
THI-administered group was not improved to the levels of the 
normal diet group (Fig. 5).
Effect of exercise on the THI-administered HFD group
Since it is well-known that exercise effectively improves the 
metabolic index, we examined whether or not THI administration Sora Han et al. 203
could act synergistically with exercise. The HFD group was 
orally administered with THI and subjected to swimming exercise 
for 10 weeks or swimming exercise without THI administration. 
Exercise induced dramatic weight loss in the THI-administered 
high-fat group (Fig. 6A) but did not alter the amount of food 
intake (Fig. 6B). Weight loss in the THI-administered exercised 
group was due to the dramatic reduction of adipose tissue (Fig. 
6C) and triglyceride levels (Fig. 6D). The simultaneous combina-
tion of exercise and THI administration induced lower levels of 
total cholesterol compared with the group that only exercised 
(Fig. 6E). These results indicate that the simultaneous combinat-
ion of exercise and THI administration has a synergistic effect 
on the reduction of total cholesterol levels and that THI does 
not affect the beneficial effect of exercise. In addition, the results 
also confirm an improvement in fasting blood glucose levels and 
oral glucose tolerance (Fig. 6F). 
Discussion
Herbal extracts have been widely used for the treatment of 
metabolic diseases, including obesity, type II diabetes, and 
hyperlipidemia. The effects of THI on metabolic diseases were 
examined using a DIO mouse model. In our system, although 
the concentration of THI required for inhibition of adipogenesis 
was quite high in vitro, potent THI metabolite was generated 
in vivo and thus may be involved in the reduction of adipose 
tissue. It is also conceivable that the reduction of body weight 
was due to reduced adipose tissue weight, as THI effectively 
inhibited adipogenesis in 3T3-L1 preadipocytes through the 
downregulation of C/EBPα  and PPARγ, which are the main 
transcription factors involved in adipogenesis. We also examined 
the possibility that THI reduced adipose tissue weight through 
increased fatty acid oxidation. However, the levels of HSL, 
ATGL, UCP-2, and CPT1a, which are involved in lipid 
mobilization and fatty acid oxidation, were not significantly 
changed. However, we cannot rule out the possibility that THI 
increases the consumption of fatty acids through another 
mechanism involving PPARδ or AMPK activation, as reduced 
adipogenesis could increase the level of fatty acids. 
The anti-obesity effects of many natural compounds are 
reported to be mediated by inhibition of adipogenesis. For 
instance, epigallocatechin gallate (EGCG), genistein, esculetin,, 
berberine, resveratrol, guggulsterone, conjugated linoleic acid, 
capsaicin, baicalein, and procyanidins are all reported to inhibit 
adipogenesis [14]. Among these, genistein, EGCG, and capsaicin 
have been shown to inhibit adipogenesis by activating AMP- 
activated protein kinase [15], and resveratrol was reported to 
increase the expression of sirtuin 1, a gene that represses expression 
of PPARγ  [16]. It may be very difficult to identify every 
molecular target of a multi-component herbal composition like 
THI, but the combined effects of its diverse actions are clearly 
the downregulation of PPARγ and C/EBPα, major transcription 
factors, as shown in Fig. 4C. PPARγ, a transcription factor of 
the nuclear-receptor superfamily, is known to be the master 
regulator of adipogenesis since it is both necessary and sufficient 
for adipogenesis [17]. The expression of PPARγ alone has been 
shown to induce adipogenesis in fibroblasts [18]. PPARγ is also 
known to induce the expression of C/EBPα by binding to its 
promoter region [19], and the THI-induced reduction of C/EBPα 
expression may be the result of decreased PPARγ expression. 
The results of this study suggest that the combined effects of 
THI are mediated through the downregulation of the major 
transcription factors of adipogenesis, PPARγ and C/EBPα. 
Orally administered THI markedly reduced serum cholesterol 
levels and fasting glucose levels while improving glucose 
tolerance. Reportedly, Scutellariae Radix  contains wogonin, a 
flavone that is known to have anxiolytic properties in mice [20] 
and potentiate the anti-tumor action of etoposide by ameliorating 
adverse effects [21]. However, there has been report that 
Scutellariae Radix has any anti-adipogenic effects. On the other 
hand, Scutellariae Radix contains baicalin [22], which is known 
to exhibit anti-inflammatory activity by binding to chemokines 
[23] or by inhibiting NF-kB [24]. Baicalin suppresses lung 
carcinoma and lung metastasis by SOD mimic and HIF-1alpha 
inhibition [25] and exerts anti-adipogenic functions through the 
maintenance of β-catenin expression [12]. Therefore, the 
observed effects of the THI extracts, such as loss of body weight 
and improved glucose tolerance, may be attributed to baicalin. 
Although platycodin saponins are known to ameliorate obesity 
and hyperlipidemia [5] as well as reduce serum triglyceride levels 
in HFD rats [6], the administration of THI-containing platycodin 
saponins did not result in decreased serum triglyceride levels. 
In the case of cholesterol, the exercised THI-administered 
high-fat group showed a decrease in cholesterol levels compared 
with the exercised high-fat group. This implies that when exercise 
and THI administration are performed simultaneously, the 
metabolic index can be improved compared to that obtained with 
only THI administration. Although it was reported that swimming 
exercise does not significantly increase glucose uptake in isolated 
skeletal muscles [26], swimming exercise alone or in combination 
with THI administration markedly improved HFD-induced 
glucose intolerance in vivo.
In conclusion, THI administration effectively reduced body 
weight, improved cholesterol level typically increased by a HFD, 
decreased fasting glucose levels, and enhanced glucose tolerance. 
Exercise training combined with THI administration also 
synergistically enhanced the effect of THI on cholesterol levels. 
These results show that THI has potential as a powerful health 
improvement substance.
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